The Central Drugs Standard Control Organization (CDSCO), India’s national regulatory authority for pharmaceuticals and medical devices, has announced a revision to the operating hours of its Public Relations Office (PRO) in New Delhi. This notice was issued on April 30, 2025.
This update aims to enhance the accessibility of regulatory guidance and support for stakeholders and innovators within the industry.
The CDSCO’s PRO will now be open to the public from 4:00 PM to 6:00 PM every day, excluding holidays. This adjustment in the schedule is intended to provide a consistent and dedicated timeframe for stakeholders to interact with CDSCO officials and seek clarification on regulatory matters.
To further streamline the interaction process, the CDSCO has allocated specific days of the week for consultations with different divisions within the organization. This division-specific schedule is designed to ensure that stakeholders can connect with the relevant experts and obtain focused guidance on their particular areas of interest.
The detailed schedule is as follows:
| Day | Division(s) | Time |
|---|---|---|
| Monday* | Medical Device & IVD* | 3:00 PM – 6:00 PM |
| Tuesday | New Drug, IND, SND & International Cell | 4:00 PM – 6:00 PM |
| Wednesday | Import & Registration, FDC & LVP | 4:00 PM – 6:00 PM |
| Thursday | Biological, Blood Products/Blood Centre & Ayush | 4:00 PM – 6:00 PM |
| Friday | BA/BE, Ethics Committee, GCT, CRO Registration CDAC/IT Cell, Veterinary & Cosmetics | 4:00 PM – 6:00 PM |
*Note: On Mondays, the PRO is open from 3:00 PM to 6:00 PM.
The CDSCO encourages all stakeholders, including pharmaceutical companies, medical device manufacturers, researchers, and other involved parties, to avail themselves of the PRO’s facilities during the designated hours and on the appropriate days. This direct interaction with CDSCO officials can be invaluable for navigating the regulatory landscape, ensuring compliance, and fostering innovation within the industry.
This public notice was officially issued by the Drugs Controller General (India).
The notice was circulated to various CDSCO officials, including all Joint Drugs Controllers (India) and Deputy/Assistant Drugs Controllers (India), and the IT Cell for uploading on the CDSCO website.
